Teladoc Inc (TDOC) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Teladoc Inc stock (TDOC) is currently trading at $5.57. Teladoc Inc PS ratio (Price-to-Sales) is 0.38. Analyst consensus price target for TDOC is $7.12. WallStSmart rates TDOC as Sell.
- TDOC PE ratio analysis and historical PE chart
- TDOC PS ratio (Price-to-Sales) history and trend
- TDOC intrinsic value — DCF, Graham Number, EPV models
- TDOC stock price prediction 2025 2026 2027 2028 2029 2030
- TDOC fair value vs current price
- TDOC insider transactions and insider buying
- Is TDOC undervalued or overvalued?
- Teladoc Inc financial analysis — revenue, earnings, cash flow
- TDOC Piotroski F-Score and Altman Z-Score
- TDOC analyst price target and Smart Rating
Teladoc Inc
📊 No data available
Try selecting a different time range
Smart Analysis
Teladoc Inc (TDOC) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book, institutional own.. Concerns around peg ratio and return on equity. Mixed signals suggest waiting for clearer direction before acting.
Teladoc Inc (TDOC) Key Strengths (3)
Paying less than $1 for every $1 of annual revenue
Trading below book value, meaning the market prices it less than net assets
76.47% of shares held by major funds and institutions
Supporting Valuation Data
Teladoc Inc (TDOC) Areas to Watch (6)
PEG ratio is negative or unavailable
Company is destroying shareholder value
Losing money on operations
Company is losing money with a negative profit margin
Revenue growing slowly at 0.30% annually
Small-cap company with higher risk but more growth potential
Supporting Valuation Data
Teladoc Inc (TDOC) Detailed Analysis Report
Overall Assessment
This company scores 38/100 in our Smart Analysis, earning a F grade. Out of 9 metrics analyzed, 3 register as strengths (avg 10.0/10) while 6 fall into concern territory (avg 1.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Price/Book, Institutional Own.. Valuation metrics including Price/Sales (0.38), Price/Book (0.69) suggest the stock is attractively priced.
The Bear Case
The primary concerns are PEG Ratio, Return on Equity, Operating Margin. Some valuation metrics including PEG Ratio (N/A) suggest expensive pricing. Growth concerns include Revenue Growth at 0.30%, which may limit upside. Profitability pressure is visible in Return on Equity at -13.90%, Operating Margin at -4.20%, Profit Margin at -7.92%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether PEG Ratio improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -13.90% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 0.30% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. PEG Ratio and Return on Equity are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
TDOC Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
TDOC's Price-to-Sales ratio of 0.38x trades at a deep discount to its historical average of 7.99x (5th percentile). The current valuation is 99% below its historical high of 30.94x set in Jan 2021, and 6% above its historical low of 0.36x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~0.5x as trailing revenue scaled faster than the stock price.
Compare TDOC with Competitors
Top HEALTH INFORMATION SERVICES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Teladoc Inc (TDOC) · HEALTHCARE › HEALTH INFORMATION SERVICES
The Big Picture
Teladoc Inc is a strong growth company balancing expansion with improving profitability. Revenue reached 2.5B with 30% growth year-over-year. The company is currently unprofitable, posting a -7.9% profit margin.
Key Findings
Revenue growing at 30% YoY, reaching 2.5B. This pace significantly outperforms most HEALTH INFORMATION SERVICES peers.
Generating 85M in free cash flow and 88M in operating cash flow. Earnings are translating into actual cash generation.
The company is unprofitable with a -7.9% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Growth sustainability: can Teladoc Inc maintain 30%+ revenue growth, or will competition slow it down?
Volatility is elevated with a beta of 2.19, so expect amplified moves relative to the broader market.
Sector dynamics: monitor HEALTH INFORMATION SERVICES industry trends, competitive moves, and regulatory changes that could impact Teladoc Inc.
Bottom Line
Teladoc Inc offers an attractive blend of growth (30% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Teladoc Inc(TDOC)
NYSE
HEALTHCARE
HEALTH INFORMATION SERVICES
USA
Teladoc Health, Inc. provides business-to-business virtual health care services in the United States and internationally. The company is headquartered in Purchase, New York.